Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Norway
/
Food, Beverage & Tobacco
/
Aker BioMarine
AKBM
Aker BioMarine
Rising Regulations And High Capital Demands Will Cripple Krill Supply
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
15 Jul 25
Updated
21 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
NOK 48.82
67.4% overvalued
intrinsic discount
21 Aug
NOK 81.70
1Y
-16.4%
7D
2.8%
Loading
1Y
-16.4%
7D
2.8%
Author's Valuation
NOK 48.8
67.4% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
NOK 48.8
67.4% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-34m
288m
2014
2017
2020
2023
2025
2026
2028
Revenue US$287.7m
Earnings US$42.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
12.75%
Food revenue growth rate
2.20%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.16%
Calculation
US$42.88m
Earnings '28
x
11.41x
PE Ratio '28
=
US$489.31m
Market Cap '28
US$489.31m
Market Cap '28
/
85.25m
No. shares '28
=
US$5.74
Share Price '28
US$5.74
Share Price '28
Discounted to 2025 @ 6.16% p.a.
=
US$4.80
Fair Value '25
US$4.80
Fair Value '25
Converted to NOK @ 10.2374 USD/NOK Exchange Rate
=
NOK 49.14
Fair Value '25
